Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ClinicalTrials.gov ID: NCT07654361

Public ClinicalTrials.gov record NCT07654361. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Pivotal Phase 3 Study to Evaluate the Long-Term Efficacy and Safety of Multiple Maintenance Doses of Once Daily Oral Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and a Weight-Related Comorbidity

Study identification

NCT ID
NCT07654361
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Industry
Enrollment
3,600 participants

Conditions and interventions

Interventions

  • Aleniglipron Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2026
Primary completion
Aug 31, 2028
Completion
Oct 31, 2028
Last update posted
Jun 21, 2026

2026 – 2028

United States locations

U.S. sites
71
U.S. states
32
U.S. cities
67
Facility City State ZIP Site status
ACCOMPLISH-1 Research Site Birmingham Alabama 35242
ACCOMPLISH-1 Research Site Birmingham Alabama 35294-3360
ACCOMPLISH-1 Research Site Phoenix Arizona 85225
ACCOMPLISH-1 Research Site Sun City West Arizona 85375
ACCOMPLISH-1 Research Site Tucson Arizona 85741
ACCOMPLISH-1 Research Site Escondido California 92025
ACCOMPLISH-1 Research Site Gardena California 92708
ACCOMPLISH-1 Research Site La Jolla California 92108
ACCOMPLISH-1 Research Site Modesto California 95355
ACCOMPLISH-1 Research Site Rolling Hills Estates California 90274
ACCOMPLISH-1 Research Site San Diego California 92123
ACCOMPLISH-1 Research Site Clearwater Florida 33756
ACCOMPLISH-1 Research Site Leesburg Florida 34748
ACCOMPLISH-1 Research Site Miami Florida 33136
ACCOMPLISH-1 Research Site Ocala Florida 34470
ACCOMPLISH-1 Research Site Ocoee Florida 34761
ACCOMPLISH-1 Research Site Pembroke Florida 33027
ACCOMPLISH-1 Research Site Tampa Florida 33617
ACCOMPLISH-1 Research Site Buford Georgia 30046
ACCOMPLISH-1 Research Site Columbus Georgia 31904
ACCOMPLISH-1 Research Site Lawrenceville Georgia 30046
ACCOMPLISH-1 Research Site Union City Georgia 30291
ACCOMPLISH-1 Research Site Woodstock Georgia 30189
ACCOMPLISH-1 Research Site Honolulu Hawaii 96814-4526
ACCOMPLISH-1 Research Site Meridian Idaho 83646
ACCOMPLISH-1 Research Site Rexburg Idaho 83440
ACCOMPLISH-1 Research Site Chicago Illinois 60637
ACCOMPLISH-1 Research Site Iowa City Iowa 52242
ACCOMPLISH-1 Research Site Wichita Kansas 67218
ACCOMPLISH-1 Research Site Louisville Kentucky 40213
ACCOMPLISH-1 Research Site Baton Rouge Louisiana 70808
ACCOMPLISH-1 Research Site Silver Spring Maryland 20901-4402
ACCOMPLISH-1 Research Site Methuen Massachusetts 01844
ACCOMPLISH-1 Research Site Needham Massachusetts 02492
ACCOMPLISH-1 Research Site Ann Arbor Michigan 48105-1912
ACCOMPLISH-1 Research Site Mankato Minnesota 56001
ACCOMPLISH-1 Research Site Richfield Minnesota 55423
ACCOMPLISH-1 Research Site Gulfport Mississippi 39503
ACCOMPLISH-1 Research Site Ridgeland Mississippi 39157
ACCOMPLISH-1 Research Site Chesterfield Missouri 63005
ACCOMPLISH-1 Research Site Hazelwood Missouri 63042
ACCOMPLISH-1 Research Site St Louis Missouri 63303-3041
ACCOMPLISH-1 Research Site Butte Montana 59701
ACCOMPLISH-1 Research Site Missoula Montana 59804
ACCOMPLISH-1 Research Site Omaha Nebraska 68198-7400
ACCOMPLISH-1 Research Site Las Vegas Nevada 89128
ACCOMPLISH-1 Research Site Albany New York 12208-3473
ACCOMPLISH-1 Research Site Brooklyn New York 11220
ACCOMPLISH-1 Research Site Charlotte North Carolina 28210
ACCOMPLISH-1 Research Site Durham North Carolina 27710-3000
ACCOMPLISH-1 Research Site Fayetteville North Carolina 28304
ACCOMPLISH-1 Research Site New Bern North Carolina 28562
ACCOMPLISH-1 Research Site Wilmington North Carolina 28401
ACCOMPLISH-1 Research Site Winston-Salem North Carolina 27104
ACCOMPLISH-1 Research Site Columbus Ohio 43213
ACCOMPLISH-1 Research Site Columbus Ohio 43215
ACCOMPLISH-1 Research Site Moore Oklahoma 73160
ACCOMPLISH-1 Research Site Portland Oregon 97202
ACCOMPLISH-1 Research Site Philadelphia Pennsylvania 19152
ACCOMPLISH-1 Research Site Greer South Carolina 29651
ACCOMPLISH-1 Research Site Knoxville Tennessee 37920
ACCOMPLISH-1 Research Site Austin Texas 78704
ACCOMPLISH-1 Research Site Austin Texas 78731
ACCOMPLISH-1 Research Site Denison Texas 75020-4582
ACCOMPLISH-1 Research Site Houston Texas 77040
ACCOMPLISH-1 Research Site Houston Texas 77054
ACCOMPLISH-1 Research Site San Antonio Texas 78231
ACCOMPLISH-1 Research Site Wylie Texas 75098
ACCOMPLISH-1 Research Site Sandy City Utah 84094
ACCOMPLISH-1 Research Site St. George Utah 84790
ACCOMPLISH-1 Research Site Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07654361, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2026 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07654361 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →